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Abstract
Defects in the MFSD8 gene encoding the lysosomal membrane protein CLN7 lead to CLN7 disease, a neurodegenerative
lysosomal storage disorder belonging to the group of neuronal ceroid lipofuscinoses. Here, we have performed a SILAC-based
quantitative analysis of the lysosomal proteome using Cln7-deficient mouse embryonic fibroblasts (MEFs) from a Cln7 knock-
out (ko) mouse model. From 3335 different proteins identified, we detected 56 soluble lysosomal proteins and 29 highly abun-
dant lysosomal membrane proteins. Quantification revealed that the amounts of 12 different soluble lysosomal proteins
were significantly reduced in Cln7 ko MEFs compared with wild-type controls. One of the most significantly depleted lysoso-
mal proteins was Cln5 protein that underlies another distinct neuronal ceroid lipofuscinosis disorder. Expression analyses
showed that the mRNA expression, biosynthesis, intracellular sorting and proteolytic processing of Cln5 were not affected,
whereas the depletion of mature Cln5 protein was due to increased proteolytic degradation by cysteine proteases in Cln7 ko
lysosomes. Considering the similar phenotypes of CLN5 and CLN7 patients, our data suggest that depletion of CLN5 may play
an important part in the pathogenesis of CLN7 disease. In addition, we found a defect in the ability of Cln7 ko MEFs to adapt
to starvation conditions as shown by impaired mammalian target of rapamycin complex 1 reactivation, reduced autolyso-
some tubulation and increased perinuclear accumulation of autolysosomes compared with controls. In summary, depletion
of multiple soluble lysosomal proteins suggest a critical role of CLN7 for lysosomal function, which may contribute to the
pathogenesis and progression of CLN7 disease.
Introduction
CLN7 disease represents a severe childhood-onset neurodegen-
erative disorder caused by mutations in the MFSD8 gene (1).
CLN7 disease belongs to the group of neuronal ceroid lipofusci-
noses (NCLs) caused by mutations in at least 13 different genes
(CLN1–CLN8, CLN10–CLN14) which encode soluble lysosomal
proteins (CLN1/palmitoyl protein thioesterase 1 (PPT1), CLN2/
tripeptidylpeptidase 1 (TPP1), CLN5, CLN10/cathepsin D and
CLN13/cathepsin F), membrane proteins located in lysosomes
(CLN3, CLN7 and CLN12) or in the endoplasmic reticulum (CLN6
and CLN8), soluble cytoplasmic proteins (CLN11/progranulin
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and CLN14) and the synaptic vesicle associated protein
CLN4 (2). More than 35 mutations have been identified in MFSD8
leading to CLN7 disease, variant-late infantile phenotype (MIM
# 610951), which is characterized by visual impairment, sei-
zures, psychomotor decline and a reduced lifespan (3–11).
MFSD8 encodes the lysosomal polytopic CLN7 membrane pro-
tein of unknown function which contains sequence similarities
with the drug: Hþ antiporter family DHA1 of the major facilitator
superfamily (MFS) (4,12). The members of the MFS are second-
ary active, ion-coupled transporters of sugars, amino acids,
drugs, nucleosides as well as organic and inorganic cations and
anions (13). CLN7 belongs to a group of atypical solute carriers
of MFS type which are located at the plasma membrane and/or
in intracellular compartments (14). Lysosomal localization
of the endogenous CLN7 protein has been demonstrated by
proteomic analyses using purified human and rat tritosomes,
by immunoblotting of mouse liver tritosomes and by immuno-
histochemical localization in cultured hippocampal neurons
(15–18). We have recently generated a Cln7 knockout (ko) mouse
model that recapitulates key features of human CLN7 disease
(19,20). In these mice, loss of Cln7 leads to (i) autofluorescence
and lysosomal storage of subunit c of mitochondrial ATP syn-
thase and saposin D in the brain and retina, (ii) neurodegenera-
tion in the olfactory bulb, cerebellum, cortex and retina, (iii)
neuroinflammation, as well as (iv) reduced lifespan of mutant
mice (19). Furthermore, dysregulated expression of several solu-
ble lysosomal proteins and impaired macroautophagy in the
Cln7 ko mice suggest that loss of Cln7 results in lysosomal dys-
function in the brain (19). However, the link between deficiency
of the putative lysosomal transporter CLN7 and lysosomal dys-
function is unclear.
Autophagy is a catabolic process where cytoplasmic compo-
nents are delivered to lysosomes for proteolytic degradation by
acidic hydrolases (21). Defective autophagy has been shown to
be a major pathomechanism contributing to the accumulation
of storage material and neurodegeneration in mouse models for
CLN2, CLN3, CLN5, CLN6, CLN7 and CLN10 diseases (19,22–26).
In this regard, the enzymatic content of lysosomes is an attrac-
tive target to study in NCLs. In CLN3 disease, which is caused by
defects in the lysosomal membrane protein CLN3, alterations in
the amounts of TPP1 (27), lysosomal acid phosphatase (28) and
mannose 6-phosphate-containing glycoproteins (29) in the
brain have been reported. However, comprehensive profiling of
the lysosomal proteome in CLN7 disease and other NCLs has
not been performed thus far.
In the present study, we provide quantitative proteomic data
that have been obtained by mass spectrometric analysis of iso-
lated lysosomes from Cln7 ko mouse fibroblasts by means of
Stable Isotope Labelling by Amino acids in Cell culture (SILAC).
We found that the loss of Cln7 results in alterations in lysoso-
mal soluble proteins under steady state conditions. In addition,
we observed a defect in the ability of Cln7 ko MEFs to adapt to
starvation conditions as shown by impaired mTORC1 reactiva-
tion, reduced numbers of cells containing tubules emerging
from autolysosomes and increased perinuclear accumulation of
autolysosomes compared with controls.
Results
Lysosomal proteome of Cln7 knockout MEFs
To analyse CLN7 disease-related changes leading to lysosomal
dysfunction, we performed a SILAC-based comparative proteo-
mics using mouse embryonic fibroblasts (MEFs) isolated from a
Cln7 knockout (Cln7 ko) mouse model that recapitulates major
hallmarks of CLN7 disease (19). Using non-radioactive light and
heavy isotope amino acids, wild-type and Cln7 ko MEFs were la-
belled in culture, and magnetite-isolated lysosomal fractions
were analysed by mass spectrometry. From 3335 different pro-
teins identified, we detected almost all known soluble lysoso-
mal proteins (number: 56) and 29 highly abundant lysosomal
membrane proteins in amounts sufficient for quantification.
Mean values of light-to-heavy ratios of >1.25-fold and <0.75-
fold determined in four individual SILAC measurements were
considered a significant increase and decrease, respectively.
Quantification revealed that the amounts of 12 different soluble
lysosomal proteins were reduced in Cln7 ko MEFs compared
with wild-type controls (Fig. 1). These included soluble
lysosomal proteins involved in the degradation of glycans
[sialate O-acetylesterase (Siae), aspartylglucosaminidase (Aga),
N-acetylglucosamine-6-sulfatase (Gns)], peptides [lysosomal
Pro-X carboxypeptidase (Prcp), carboxypeptidase Q (Cpq),
dipeptidyl peptidase 2 (Dpp7)], lipids [N-acylethanolamine-
hydrolyzing acid amidase (Naaa), group XV phospholipase A2
(Pla2g15)] and fatty acid-modified proteins [prenyl cysteine oxi-
dase (Pcyox1)]. In addition, the levels of lysosomal proteins of
unknown function including Niemann Pick type C2 protein
(Npc2), neuronal ceroid-lipofuscin protein 5 (Cln5) and mamma-
lian ependymin-related protein 1 (Epdr1) were decreased in
Cln7 ko MEFs in comparison to wild-type control cells (Fig. 1).
Three soluble lysosomal proteins were detected in significantly
elevated amounts in Cln7 ko MEFs compared with wild-type
controls: cathepsin S (Ctss, 13.4-fold), cathepsin K (Ctsk, 2.2-
fold), and prosaposin (Psap, 1.25-fold). These data showed that
the absence of functional Cln7 protein affects the amounts of
multiple soluble lysosomal proteins.
Alterations of lysosomal proteins in Cln7-deficient cells
and tissues
To verify the proteomic data, expression levels of selected lyso-
somal enzymes were determined by immunoblotting, enzy-
matic activity measurements and mRNA quantification (Fig. 2).
In agreement with the comparative proteomic data, the
amounts of Cln5 and Dpp7 were decreased by about 80% and
75%, respectively, in Cln7 ko MEFs compared with wild-type
controls as shown by western blotting (Fig. 2A). The enzymatic
activities of b-hexosaminidase (Hexb), b-galactosidase (Glb) and
b-glucuronidase (Gusb) were not changed in Cln7 ko MEFs com-
pared with controls; however, we observed a 1.5-fold increase in
the enzymatic activity of a-mannosidase (Man) in Cln7 ko MEFs
(Fig. 2B). To analyse whether changed mRNA amounts contrib-
ute to altered levels of dysregulated lysosomal proteins, quanti-
tative RT-PCR analyses were performed. The mRNA amounts of
Ppt1, Prcp, Siae, Glb1, Npc2, Tpp1, Cln5 and Ctsd were not changed
in Cln7 ko MEFs compared with wild-type controls (Fig. 2C).
mRNA expression of Aga, Psap, Naaa, Irgm1, Dpp7, arylsulfatase B
(Arsb) and Epdr1 were significantly reduced in Cln7-deficient
MEFs.
In order to verify dysregulated lysosomal proteins in Cln7 ko
cells and tissues, western blot analyses were performed on pri-
mary mouse Cln7 ko macrophages, Cln7 ko brain tissue, and in
the human HAP1 CLN7 ko cell line (Fig. 3). Immunoblot analyses
showed that the Cln5 protein levels were decreased by 50% and
the Ctss levels were elevated 2-fold in Cln7 ko macrophages
compared with wild-type controls (Fig. 3A). Cathepsin B (Ctsb)
levels were not altered in Cln7 ko macrophages. In the human
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CLN7 ko HAP1 cells, amounts of the NCL-related proteins—
CLN5, cathepsin D (CTSD) and PPT1—were significantly reduced
in comparison with wild-type cells (Fig. 3B). Both precursor and
mature CLN5, CTSD and PPT1 proteins could be detected, indi-
cating their correct targeting and proteolytic processing in CLN7
ko lysosomes. Soluble lysosomal glucocerebrosidase (GBA) and
the lysosomal membrane proteins SIDT2 and lysosome-
associated membrane protein 2 (LAMP2) remained unaltered in
CLN7-deficient HAP1 cells, suggesting that the reduction in
the three NCL-related proteins was not due to decreased num-
ber of lysosomes or impaired lysosomal integrity (Fig. 3B).
Immunoblot analyses showed a reduction of Cln5 protein levels
by 75% in Cln7 ko brain tissue compared with wild-type controls
(Fig. 3C). These data indicate that depletion of selected soluble
lysosomal proteins in Cln7 ko cells and tissues is not cell-type
specific.
Enhanced degradation of Cln5 by cysteine proteases in
Cln7-deficient MEFs
To examine whether mistargeting contributes to the depletion
of mature Cln5 protein in Cln7-deficient cells, total cell extracts,
lysosome-enriched fractions and conditioned media from Cln7
ko and control MEFs were collected and analysed by immuno-
blotting (Fig. 4A). In cell extracts and lysosomal fractions of Cln7
ko and wild-type MEFs, a 55 kDa precursor and a 50 kDa mature
Cln5 form were detected, indicating correct targeting and pro-
teolytic processing of Cln5 in lysosomes in the absence of Cln7.
Similarly to the previous observations, the amounts of mature
Cln5 were reduced in both total protein extracts and lysosomal
fractions of Cln7 ko MEFs compared with controls. The amounts
of secreted Cln5 precursor protein were comparable in MEFs of
both genotypes indicating that Cln5 is not missorted into the
medium in the absence of Cln7 (Fig. 4A). The levels of the
lysosomal-associated membrane protein 1 (Lamp1) were
unchanged in Cln7 ko MEFs compared with controls, suggesting
no difference in the number of lysosomes between MEFs of both
genotypes.
To analyse whether increased turnover contributes to re-
duced amounts of mature Cln5 in Cln7 ko lysosomes, we cul-
tured MEFs in the presence of cysteine and aspartyl protease
inhibitors and analysed total cell extracts by immunoblotting
(Fig. 4B). Treatment of Cln7 ko cells with the cysteine protease
inhibitors leupeptin or E64 resulted in significantly increased
amounts of mature Cln5 compared with water-treated control
MEFs. In contrast, incubation of Cln7 ko MEFs with the aspartyl
Figure 1. SILAC-based comparative analysis of lysosomal proteomes of wild-type and Cln7 ko MEFs. Wild-type (wt) and Cln7 knockout (ko) MEFs were grown in heavy
and light isotope-labelled medium and incubated in medium containing magnetite particles for 24 h, followed by 36 h of chase. Equal amounts of postnuclear superna-
tants from MEFs of both genotypes were pooled prior to magnetic isolation of lysosomes and MS analysis. Soluble lysosomal proteins identified in the lysosomal frac-
tions by MS analysis were plotted against the Cln7 ko/wt ratio determined in four individual SILAC samples (mean 6 SD). Lysosomal proteins with increased
and decreased amounts in Cln7 ko lysosomes are indicated with red and blue circles, respectively. A list of all lysosomal proteins identified and the corresponding
Cln7 ko/wt ratios are given in the Supplementary Material (Tables S1 and S2).
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protease inhibitor pepstatin A did not affect the levels of Cln5
compared with DMSO-treated control MEFs. Inhibition of lyso-
somal acidification by the vacuolar-type Hþ-ATPase inhibitor
bafilomycin A1 led to a reduced proteolytic processing to the
mature Cln5 protein in MEFs of both genotypes and abolished
processing of Ctsb. The levels of Ctsb and Lamp1 were not
changed between Cln7 ko and wild-type MEFs at steady state
(Fig. 4B). These data indicate that the depletion of mature Cln5
protein in Cln7 ko MEFs is due to its increased proteolytic degra-
dation by cysteine proteases in lysosomes. CLN5 has been pro-
posed to be synthesized as a type II membrane precursor
protein which undergoes proteolytical cleavage in acidic com-
partments generating a mature protein that is tightly associated
with lysosomal membranes via an amphipathic helix (30). To
analyse whether altered membrane association of mature Cln5
might contribute to its increased proteolytic degradation in
Cln7 ko lysosomes, we performed subcellular fractionation
studies. In cells treated in the presence of E64, the majority of
Cln5 was found in the soluble lysosomal fraction with a minor
amount in the membrane fraction of both wild-type and Cln7
ko MEFs (Supplementary Material, Fig. S1A). Incubation of mem-
branes with sodium carbonate completely released the
membrane-associated fraction of Cln5 in MEFs of both geno-
types. The amounts of Cln5 secreted into the media were not al-
tered in Cln7 ko MEFs incubated in the presence of E64
compared with wild-type controls (Supplementary Material, Fig.
S1B). Our data suggest that the distribution of soluble and
membrane-associated Cln5 in lysosomes is not changed due to
the absence of Cln7.
Attenuated mTORC1 reactivation during starvation in
Cln7 knockout MEFs
The mTOR complex 1 (mTORC1) regulates cell metabolism in re-
sponse to environmental stimuli. Under nutrient starvation
mTOR signalling is inactive, whereas amino acids provided by
the degradation of autophagic substrates reactivate the
mTORC1 pathway (31,32). Since dysregulated Mfsd8 mRNA ex-
pression levels upon amino acid starvation in a mouse hypotha-
lamic cell line were reported (14), we analysed the effects of
amino acid withdrawal in Cln7 ko MEFs. To investigate whether
loss of Cln7 affects inactivation and reactivation of mTORC1, we
monitored phosphorylation of the S6 ribosomal protein (S6), a
downstream target of the mTORC1 pathway, during prolonged
starvation in wild-type and Cln7 ko MEFs (Fig. 5A and B). In cells
of both genotypes starved for 2 h, phosphorylation of S6 was
completely inhibited, whereas after 4 h of starvation we ob-
served recovery of S6 phosphorylation which was gradually in-
creasing over time in MEFs of both genotypes. However, in Cln7
ko MEFs, the levels of phospho-S6 were significantly decreased
after 8 and 12 h of starvation in comparison with control cells,
indicating impaired mTOR signalling during ongoing starvation.
Both in Cln7 ko and wild-type MEFs, phosphorylation of S6 was
completely blocked in the presence of torin 1, a selective inhibi-
tor of mTOR (Fig. 5A and B). To identify possible defects in basal
and starvation-induced autophagy, Cln7 ko and control MEFs
were starved for up to 12 h in amino acid- and serum-free
medium and were analysed by immunoblotting using
microtubule-associated protein 1 light chain 3B (MAP1LC3B) and
the autophagic cargo receptor SQSTM1/p62 as marker proteins
for autophagic protein turnover (Fig. 5A and B). Under basal con-
ditions, levels of LC3-II in MEFs of both genotypes were compa-
rable, which indicated similar number of autophagosomes in
these cells. Under prolonged starvation, LC3-II and p62 levels in
Cln7 ko MEFs decreased similarly to those in control MEFs, re-
flecting unchanged autophagy-mediated degradation of both
proteins in Cln7 ko lysosomes (Fig. 5A and B). To measure auto-
phagic flux, Cln7 ko and wild-type MEFs were incubated in the
presence of bafilomycin A1 in complete or in amino acid- and
serum-free starvation medium for 0.5 or 2 h (Fig. 5C). By inhibit-
ing lysosomal acidification, bafilomycin A1 blocks the degrada-
tion inside lysosomes, resulting in the accumulation of both
Figure 2. Validation of SILAC data using Cln7 ko and wild-type MEFs. (A) Whole cell lysates (WCL) and lysosome-enriched fractions (LF) of Cln7 ko and wild-type MEFs
were analysed by Cln5, Dpp7, cathepsin D (Ctsd) and cathepsin B (Ctsb) immunoblotting. a- and b-tubulin western blotting was performed to control equal loading. The
positions of the molecular mass markers and the precursor, intermediate and mature forms of Cln5, Ctsb and Ctsd are indicated with white, grey and black arrow-
heads, respectively. (B) Specific enzymatic activities of b-hexosaminidase (Hex), b-galactosidase (Glb), b-glucuronidase (Gusb) and a-mannosidase (Man) in whole cell
lysates of wild-type and Cln7 ko MEFs. The activities relative to wild-type controls are shown (mean 6 SD, *P < 0.05, n ¼ 4, two-tailed Student’s t-test). (C) Relative
mRNA expression levels of selected lysosomal genes in Cln7 ko MEFs in comparison to wild-type controls (set as 1.0). Data are plotted as mean values 6 SD (*P < 0.05,
**P < 0.01, ***P < 0.001, n ¼ 3–6, two-tailed Student’s t-test). n.d.: not detected.
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LC3-II and p62 (33). Western blot analyses of total cell extracts
revealed comparable levels of LC3-II and p62 in bafilomycin-
treated cells of both genotypes, suggesting that neither basal
nor starvation-induced autophagic flux was compromised in
Cln7 ko MEFs (Fig. 5C). By performing a similar experiment using
primary hepatocytes we confirmed that autophagic flux was not
affected in cells lacking Cln7 (Supplementary Material, Fig. S2B).
To analyse whether Cln7 deficiency impairs amino acid-
dependent mTORC1 reactivation, MEFs were starved for 1 h
in serum- and amino acid-free medium followed by the re-
addition of amino acids and incubation for 0.5–3 h. mTORC1
inactivation and reactivation was monitored by the phosphory-
lation status of the mTORC1 downstream target p70 S6 kinase
(p70S6K). As demonstrated by immunoblotting, withdrawal of
amino acids and serum for 1 h resulted in a complete loss of
phosphorylation of p70S6K in both Cln7 ko and wild-type MEFs
(Fig. 5D, upper panel). Amino acid replenishment rapidly re-
stored phosphorylation of p70S6K in MEFs of both genotypes,
indicating that mTORC1 reactivation by amino acids is indepen-
dent of Cln7. As negative control, starved cells were incubated
with amino acids in the presence of the mTOR inhibitor torin 1
(Fig. 5D, upper panel). In both genotypes, phosphorylation of the
mTORC1 substrate p70S6K was completely blocked by torin 1.
To analyse whether mTORC1 reactivation by amino acids gener-
ated by protein degradation in starved Cln7 ko MEFs is impaired,
we incubated Cln7 ko and wild-type MEFs in the presence of
BSA after amino acid/serum starvation (Fig. 5D, lower panel). In
both Cln7 ko and wild-type MEFs we observed phosphorylation
of p70S6K which increased over time and was not altered com-
pared with control cells. In control experiments using Cln7 ko
and control MEFs incubated in the presence of torin 1, phos-
phorylated p70S6K was not detected indicating a complete si-
lencing of BSA-dependent mTOR signalling by the inhibitor
(Fig. 5D, lower panel). To rule out proteolytic degradation of
added BSA in the medium, we analysed phosphorylation of
p70S6K in cells treated with BSA in the presence of bafilomycin
A1. We did not observe phosphorylation of p70S6K in
bafilomycin-treated cells, indicating that mTORC1 reactivation
by BSA in starved wild-type and Cln7 ko cells was due to the
amino acids generated by degradation of intact endocytosed
BSA in lysosomes (Fig. 5D, lower panel).
At the terminating stages of autophagy, when mTORC1 ac-
tivity increases, the process of autophagic lysosome reforma-
tion (ALR) causes the generation of tubular structures extending
from autolysosomes (34). To analyse whether ALR is also af-
fected in the absence of Cln7, we starved wild-type and Cln7 ko
MEFs for up to 12 h in amino acid- and serum-free medium and
visualized Lamp1-positive lysosomes by immunofluorescence
microscopy. After 12 h of starvation we observed formation of
Lamp1-positive tubular structures in 65% of wild-type cells
Figure 3. Decreased Cln5 protein amounts in Cln7 ko cells and brain tissue. (A) Primary bone macrophages isolated from 5-month-old Cln7 ko and age-matched wild-
type mice (N ¼ 3) were cultivated for 14 days. Whole cell lysates were analysed by immunoblotting using antibodies against Cln5, cathepsins S (Ctss) and B (Ctsb).
Equal loading was verified by a-tubulin western blotting. The positions of the molecular mass markers and the precursor (open arrowhead) and mature (filled arrow-
head) Cln5 and Ctsb proteins, respectively, are indicated. Densitometric quantification of the immunoreactive band intensities has been performed and the relative
protein amounts are shown in a bar diagram (mean 6 SD, n ¼ 3–5). n.s.: not significant, *P < 0.05 (two-tailed Student’s t-test). (B) Lysosome-enriched fractions of CLN7
ko and wild-type HAP1 cells were analysed by western blotting using antibodies against CLN5, cathepsin D (CTSD), PPT1, glucocerebrosidase (GBA), SIDT2 and LAMP2.
Equal loading was confirmed by a-tubulin western blotting. The positions of the molecular mass markers and the precursor (open arrowhead) and mature (filled arrow-
head) forms of CLN5, CTSD and PPT1, respectively, are indicated. (C) Whole brain lysates from three 10-month-old Cln7 ko and age-matched wild-type mice were ana-
lysed by Cln5 immunoblotting. b-Tubulin western blotting was used as loading control. The positions of the molecular mass markers are indicated. Bar diagram
represents densitometric analysis of Cln5 protein levels normalized to the loading control (mean6 SD, n ¼ 5). *P < 0.05 (two-tailed Student’s t-test).
1715Human Molecular Genetics, 2018, Vol. 27, No. 10 |
Downloaded from https://academic.oup.com/hmg/article-abstract/27/10/1711/4921282
by Institute of Child Health/University College London user
on 03 May 2018
(Supplementary Material, Fig. S4A and B). Quantification re-
vealed that the fraction of Cln7 ko MEFs containing tubular
structures was significantly lower compared with wild-type
controls after 12 h of starvation (20% versus 65%,
Supplementary Material, Fig. S4B). These Lamp1-positive tubu-
lar structures emerging from autolysosomes were associated
with microtubules which are required for ALR (Supplementary
Material, Fig. S4A) (34). In addition, both under non-starvation
and 12-h starvation conditions the perinuclear Lamp1 intensity
was significantly higher in Cln7 ko MEFs compared with wild-
type controls (Supplementary Material, Fig. S4C).
Discussion
Loss of Cln7 in the brain and retina of mice leads to lysosomal
dysfunction, impaired macroautophagy and neurodegeneration
(19,20). The molecular mechanisms and the link between the
deficiency of the putative lysosomal transporter CLN7 and lyso-
somal dysfunction are unclear. Our comparative analyses of the
lysosomal proteome of Cln7 ko MEFs showed that multiple solu-
ble lysosomal enzymes involved in the degradation of glycans,
peptides, lipids and fatty acid-modified proteins were signifi-
cantly depleted in lysosomes in the absence of functional Cln7
(Fig. 1 and Supplementary Material, Table S1). In contrast, none
of the identified membrane proteins was significantly altered in
Cln7-deficient lysosomes (Supplementary Material, Table S2).
To our knowledge, this report is the first to describe the lysoso-
mal proteome of cells defective in an NCL-related lysosomal
membrane protein.
Since Cln5 was one the most significantly depleted soluble
lysosomal protein in Cln7 ko lysosomes and mutations in the
CLN5 gene lead to CLN5 disease with a phenotype resembling
that observed in CLN7 patients (1), we focused our analyses on
expression, sorting and processing of Cln5 in Cln7-deficient
MEFs (Figs 2–4). The function of the highly N-glycosylated Cln5
protein is unknown, but it has recently been proposed to func-
tion as a glycoside hydrolase in Dictyostelium and in humans
(35). In the present study, decreased levels of CLN5 protein were
observed in human CLN7 ko HAP1 cells, in Cln7 ko MEFs, in pri-
mary Cln7 ko mouse macrophages and in mouse brain, indicat-
ing cell type-independent depletion of CLN5 in the absence of
CLN7. Our studies showed that reduced Cln5 levels in Cln7 ko
lysosomes were not due to decreased mRNA transcription, mis-
sorting, or altered proteolytic processing. Rather, expression
analyses in the presence of lysosomal protease inhibitors dem-
onstrated that enhanced degradation by lysosomal cysteine
proteases was primarily responsible for depletion of Cln5 in
Cln7 ko lysosomes (Fig. 4). The similar disease onset, progres-
sion and phenotypes of CLN5 and CLN7 patients in combination
with the observed depletion of Cln5 in Cln7 ko cells and tissues
suggest that CLN7 and CLN5 may act in a common pathway
which is disturbed in both diseases. Our findings along with the
Figure 4. Increased turnover of Cln5 by cysteine proteases in Cln7 ko lysosomes. (A) Wild-type and Cln7 ko MEFs were incubated in Opti-MEM medium for 24 h.
Lysosome-enriched fractions (LF, 50 mg protein), whole cell extracts (100 mg protein) and conditioned media (20%) were analysed by western blotting using anti-Cln5
and anti-Lamp1 antibodies. Equal loading in LF and total cell extracts was confirmed by Lamp1 and Gapdh immunoblotting, respectively. The positions of the molecu-
lar mass markers and the precursor (p, open arrowhead) and mature (m, filled arrowhead) Cln5 proteins are indicated. Densitometric quantification of the immunore-
active band intensities from four independent experiments has been performed and the percentage of secreted Cln5 precursor forms related to the total amount of
Cln5 is shown in a bar diagram (mean 6 SD). n.s.: not significant (two-tailed Student’s t-test). (B) Wild-type and Cln7 ko MEFs were incubated in the presence of leupep-
tin (Leu, 100 mM), pepstatin A (Pep A, 30 mM), E64 (50 mM) or bafilomycin A1 (Baf A1, 100 nM) for 20 h. Water- and DMSO-treated cells served as negative controls for leupep-
tin/E64- and pepstatin/bafilomycin-treated cells, respectively. Whole cell extracts (75 mg protein) were analysed by immunoblotting using antibodies against Cln5,
cathepsin B (Ctsb) and Lamp1. Equal loading was confirmed by Gapdh western blotting. The positions of the molecular mass markers as well as the precursor (p, open
arrowhead) and mature (m, filled arrowhead) Cln5 and Ctsb proteins, respectively, are indicated. Densitometric quantification of the immunoreactive band intensities
from at least three independent experiments was performed, and the total Cln5 protein amount was calculated (mean 6 SD) relative to water or DMSO controls (set as
1.0). n.s.: not significant, *P < 0.05 compared with a corresponding negative control (two-tailed Student’s t-test).
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reported interactions of CLN5 with many of the known NCL pro-
teins like PPT1, TPP1, CLN3, CLN6 and CLN8, support an essen-
tial role of CLN5 in the NCL network (36,37).
Our quantitative proteome and immunoblot analyses re-
vealed a depletion of PPT1 and CTSD in lysosomes in the
absence of CLN7 (Fig. 3). Significant deficiency in CTSD and PPT1
in humans leads to CLN1 and CLN10 disease, respectively (1). Of
note, PPT1 has previously been reported to interact both with
CTSD in the neuroblastoma cell line SH-SY5Y (38) and with
CLN5 (37), whereas the Dictyostelium discoideum Ctsd homologue
Figure 5. mTORC1 reactivation upon starvation is impaired in Cln7 ko MEFs. (A) Wild-type (wt) and Cln7 ko MEFs were either incubated in the presence of serum and
amino acids for 12 h or starved for 2, 4, 6, 8 or 12 h in amino acid-deficient EBSS medium lacking serum. MEFs starved in EBSS in the presence of the mTOR inhibitor
torin 1 for 12 h were used as controls. Total cell extracts were prepared and analysed by phospho-S6 (p-S6; Ser235/236), S6, LC3 and SQSTM1/p62 immunoblotting.
Equal loading was confirmed by b-tubulin western blotting. The positions of the molecular mass markers are indicated. (B) Densitometric analysis of the immunoreac-
tive band intensities shown in (A). Data from at least three independent experiments were analysed. Results are shown as mean6 SD. ***P < 0.001, **P < 0.01 (two-tailed
Student’s t-test). (C) Wild-type and Cln7 ko MEFs were incubated either in complete culture medium (fed) containing bafilomycin A1 (Baf A1, 100 nM) or in amino acid-
and serum-free EBSS medium in the absence or presence of Baf A1 (starved) for 0.5 or 2 h. Total cell extracts were analysed by LC3 and SQSTM1/p62 immunoblotting.
b-Tubulin immunoblotting was used as loading control. The positions of the molecular mass markers are indicated. (D) Wild-type and Cln7 ko MEFs were starved for
amino acids and serum in EBSS medium for 1 h. Cells were either harvested or mTORC1 was re-activated by DMEM containing amino acids (aa, upper panel) or EBSS
containing 3% (w/v) BSA (lower panel) for 30, 60, 120 and 180 min. MEFs incubated in DMEM in the presence of the mTOR inhibitor torin 1 (upper panel) or incubated in
EBSS/3% BSA containing torin 1 or Baf A1 (lower panel) for 180 min were used as controls. Non-starved MEFs incubated in medium containing amino acids and serum
were used as additional controls. Total cell extracts were prepared and analysed by phospho-p70S6K (p-p70S6K; Thr389) and p70S6K immunoblotting. The positions of
the band corresponding to phospho-p70S6K and an unspecific band are marked with an arrow and an asterisk, respectively (lower panel). Equal loading was confirmed
by b-tubulin western blotting. The positions of the molecular mass markers are indicated.
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has been found in the CLN5 interactome (35). The combined de-
pletion of Cln5, Ppt1 and Ctsd, which we observed in Cln7 ko
MEFs, may play a specific role in the pathogenesis of CLN7 dis-
ease. Since changes in lipid and cholesterol metabolism have
been shown in the brains of Cln1 ko and Cln5 ko mouse models,
it is tempting to speculate that CLN7 deficiency may affect lipid
metabolism in lysosomes (39–41).
The comparative proteome analyses of Cln7 ko lysosomes
demonstrated quite modest alterations in soluble lysosomal en-
zymes (<2-fold for most of the altered proteins). Therefore, we
hypothesized that challenging Cln7-deficient cells by nutrient
depletion may reveal even more prominent defects. Basal
mTORC1 activity and starvation-induced mTORC1 inactivation
were comparable in Cln7 ko and wild-type MEFs (Fig. 5).
However, under prolonged starvation we observed that reacti-
vation of mTOR signalling was significantly impaired in Cln7 ko
MEFs compared with controls. We then raised the question
whether altered basal autophagy or autophagic flux may cause
impaired mTORC1 reactivation during prolonged starvation in
the absence of functional Cln7. We did not observe any defects
in the autophagic degradation rate due to the absence of Cln7,
as shown by an unaltered autophagic flux (Supplementary
Material, Fig. S2) and a normal turnover of the autophagosomal
marker protein LC3-II and the autophagy substrate p62 during
starvation (Fig. 5A and B). Furthermore, we did not detect alter-
ations in autophagosome-lysosome fusion in the course of
autophagy, as shown by partial localization of LC3 puncta inside
lysosomes (Supplementary Material, Fig. S2A), which suggested
that early steps of autophagy were not affected in Cln7 ko
cells. Taken together, our findings indicate that impaired
mTORC1 reactivation during starvation in the absence of Cln7
is not caused by defects in basal or starvation-induced
macroautophagy.
Amino acids present in the lysosomal lumen are potent acti-
vators of mTORC1 (42). To analyse whether impaired mTORC1
reactivation in Cln7 ko MEFs during prolonged starvation was
due to defective transport of amino acids from lysosomes, we
monitored mTOR activity after replenishment with amino acids
or BSA (Fig. 5D). Activation of mTORC1 by amino acids was not
altered in Cln7 ko cells either, indicating that the mTOR protein
complex 1 is recruited to lysosomes, is functional, and responds
to stimuli independently of loss of Cln7. Similarly, adding BSA
extracellularly was sufficient to reactivate silenced mTOR sig-
nalling, which argued against proteolytic dysfunction of Cln7-
deficient lysosomes, at least upon short-term starvation.
Normal mTORC1 activities under basal and nutrient-replete
conditions in Cln7 ko MEFs suggest that Cln7 is not involved in
the transport of amino acids outside of lysosomes. Finally,
taken together with unaltered turnover of LC3-II and p62,
unchanged processing of soluble lysosomal enzymes (Ctsb,
Ctsd, Cln5 and Ppt1), and enhanced cysteine protease-mediated
degradation of Cln5 in Cln7 ko cells, these data suggest that im-
paired mTORC1 reactivation during amino acid starvation is not
due to defective proteolytic capacity of Cln7 ko lysosomes at
steady state.
In agreement with impaired mTORC1 reactivation during
starvation in Cln7-defective cells, we observed an increased
localization of enlarged autolysosomes in the perinuclear region
of Cln7 ko cells and decreased numbers of Cln7 ko MEFs con-
taining tubular structures extending from autolysosomes com-
pared with controls (Supplementary Material, Fig. S4) (34,43).
These findings suggest a defect in autophagic lysosome refor-
mation (ALR) during starvation in Cln7 ko MEFs. Impaired ALR
in starved Cln7 ko cells may lead to a depletion of newly
generated functional lysosomes, which ultimately could aggra-
vate lysosomal dysfunction in Cln7-deficient cells. Interestingly,
after prolonged starvation for 24 h, we observed decreased lev-
els of cathepsins B and D in Cln7 ko MEFs compared with con-
trols (Supplementary Material, Fig. S3). Supporting these data,
decreased amounts and reduced enzymatic activities of cathep-
sins B and D have previously been proposed to cause delayed
ALR via impairment of mTOR signalling reactivation (44).
Impaired mTORC1 reactivation and defective ALR during pro-
longed starvation have also been demonstrated in fibroblasts
derived from patients with lysosomal storage disorders such as
Scheie syndrome, Fabry disease and aspartylglucosaminuria
(34), in cystinosin-deficient kidney cells (45) and in normal rat
kidney cells depleted in the lysosomal MFS transporter Spinster
(46). In spin knockdown cells starved for 12 h, reduced enzy-
matic activities of Ctsd were found, and the authors suggested
that defective mTOR signalling causes impaired degradation in
autolysosomes (46). Noteworthy, in the brain of Drosophila spin
mutants an NCL-like phenotype, characterized by storage of lip-
ofuscin, accumulation of ceramides, age-dependent synaptic
dysfunction and progressive neurodegeneration, was reported
(47,48), suggesting that impaired ALR and mTORC1 reactivation
may contribute to lysosomal/autolysosomal dysfunction in
other NCLs. In agreement, downregulation of mTOR signalling
and dysfunction in the mTORC1 pathways have been reported
in mouse and yeast models of juvenile CLN3 disease, respec-
tively (23,49).
In summary, our data show that loss of functional Cln7 pro-
tein affects the amounts of multiple soluble lysosomal proteins.
The combined depletion of several NCL-related lysosomal pro-
teins including Ctsd, Ppt1 and Cln5 may contribute to lysosomal
dysfunction in Cln7-deficient fibroblasts. In addition, we found
a defect in the ability of Cln7 ko MEFs to adapt to prolonged star-
vation conditions as shown by impaired mTORC1 reactivation,
reduced tubulation of autolysosomes and increased perinuclear
accumulation of autolysosomes. The exact role of CLN7 in
mTOR signalling during long-term starvation and its relevance
in neuronal cells, however, remains to be elucidated and will be
addressed in future studies.
Materials and Methods
Antibodies and reagents
Primary antibodies were: goat anti-mouse cathepsin B
(Neuromics, GT15047), goat anti-mouse cathepsin D (Santa Cruz,
sc6486), monoclonal mouse anti-a-tubulin (Sigma, T9026), poly-
clonal rabbit anti-Cln5 (Abcam, ab170899), polyclonal goat anti-
cathepsin S (Santa-Cruz, sc6503), polyclonal goat anti-mouse
Dpp7 (R&D, AF3436), polyclonal rabbit anti-glucocerebrosidase
(Sigma, G4171), polyclonal rabbit anti-LC3B/MAP1LC3B (Novusbio,
NB100–2220), polyclonal rabbit anti-p62 (Enzo Life Sciences, BML-
PW9860), polyclonal rabbit anti-human PPT1 (Millipore, ABS1118),
polyclonal rabbit anti-glyceraldehyde-3-phosphate dehydroge-
nase (Gapdh, Santa Cruz, sc25778), polyclonal rabbit anti-SIDT2
(Thermo Fischer Scientific, PA5–34493). Monoclonal rabbit anti-S6
ribosomal protein (clone 5G10), monoclonal rabbit anti-phospho-
S6 ribosomal protein (Ser235/236, clone D57.2.2E), monoclonal
rabbit anti-p70 S6 kinase (clone 49D7) and monoclonal rabbit
anti-phospho-p70 S6 kinase (Thr389, clone 108D2) were from Cell
Signalling. The monoclonal rat anti-mouse Lamp1 antibody
(clone 1D4B), rat anti-mouse Lamp2 (clone ABL-93) and mouse
anti-human LAMP2 (clone H4B4) developed by J. Thomas August,
and the monoclonal mouse anti-b-tubulin antibody (clone E7)
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developed by M. Klymkowsky were obtained from the
Developmental Studies Hybridoma Bank, created by the NICHD
of the NIH and maintained at the Department of Biology,
University of Iowa, Iowa City, USA. Secondary goat anti-mouse,
goat anti-rabbit, rabbit anti-goat and goat anti-rat antibodies cou-
pled to horseradish peroxidase or Alexa FluorVR -fluorophores
were from Dianova.
KAPATM Mouse Genotyping Hot Start Kit and Peqgold Total
RNA kit were from VWR. Nitrocellulose and PVDF membranes
were purchased from GE Healthcare Life Sciences and Roche, re-
spectively. Albumin standard, restriction enzymes, RT-PCR
TaqManVR gene expression assays, High Capacity cDNA Reverse
Transcription kit, reagents for SILAC labelling of MEFs and en-
hanced chemiluminescence (ECL) reagent were from Thermo
Fisher Scientific. Protease-free bovine albumin (fraction V) was
from Serva. Gel extraction and PCR purification kits were from
Qiagen. DMEM, IMDM, RPMI-1640, EBSS, Opti-MEM media and
Glutamax were purchased from Gibco. Leupeptin, pepstatin A,
E64, bafilomycin A1, b-glucosidase from almonds, 4-methylum-
belliferone, enzyme substrates (Supplementary Material, Table
S3) and protease inhibitor cocktail were from Sigma. Torin 1
was purchased from Tocris Bioscience and phosphatase inhibi-
tor cocktail (PhosSTOP) was from Roche. Macrophage colony-
stimulating factor was from Peprotech. Dextran-stabilized mag-
netite particles were purchased from Liquids Research Ltd., and
isolation of lysosomes was performed using MACS LS
Separation columns from Miltenyi Biotec.
Cell culture
Immortalized wild-type and Cln7 ko MEFs were described previ-
ously (19) and cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum (FBS),
Glutamax and penicillin/streptomycin. A Clustered Regularly
Interspaced Short Palindromic Repeats (CRISPR)-Cas9 edited hu-
man haploid HAP1 MFSD8 knockout cell line was commercially
obtained from Horizon Discoveries (Vienna, Austria) and was
generated by a 20 bp deletion in exon 4 of the human MFSD8
gene. HAP1 cells were cultured in Iscove’s modified Dulbeccos’s
medium (IMDM) supplemented with 10% FBS, Glutamax and pen-
icillin/streptomycin. Primary bone marrow macrophages were
isolated from 5-month-old mice and maintained in RPMI-1640
medium containing 10% FBS, Glutamax, penicillin/streptomycin
and 50 ng/ml macrophage colony-stimulating factor (M-CSF).
All cells were cultured at 37C, in a humidified atmosphere
containing 5% CO2.
Stable isotope labelling by amino acids of cultured MEFs
and proteome analysis of lysosomal fractions
Labelling of immortalized MEFs with light and heavy isotopes
and subsequent isolation of magnetite-loaded lysosomes was
performed as described previously (50). Briefly, immortalized
Cln7 ko and wild-type MEFs were cultured for six passages in
DMEM for SILAC supplemented with 10% FBS and conventional
light- (Arg/Lys) or heavy-labelled (Arg (13C156 N4)/Lys (
13C156 N2) iso-
topes at concentrations of 87.8 mg/l (Arg) and 181.2 mg/l (Lys)).
Prior to lysosomal isolation, the cells were incubated in the cor-
responding light- or heavy-labelled medium supplemented
with 10% dextran-stabilized magnetite particles for 24 h. After
removal of the magnetic beads, fresh medium was added for a
36 h chase time. Postnuclear supernatants of Cln7 ko and wild-
type MEFs were prepared, mixed and magnetite-containing
lysosomes were isolated using a Miltenyi LS magnetic column.
Preparation of lysosomal fractions for mass spectrometry analy-
ses was performed as described previously (50).
Experimental animals
Cln7 ko mice have been described previously (19). Animals were
maintained under standard housing conditions on a 12 h light
and 12 h dark schedule in a pathogen-free animal facility at the
University Medical Center. Removal of tissues was approved by
the local animal welfare officer (ORG769).
Isolation and culture of bone marrow derived
macrophages
Experimental mice were sacrificed in a CO2 chamber and femurs
and tibias were aseptically removed. The bone marrow was
then flushed out with RPMI medium supplemented with 10%
FBS, Glutamax and penicillin/streptomycin. The obtained cell
suspension was filtered through a 70 mm cell strainer, and the
cells were finally plated at a density of 5  105 cells/cm2. In order
to induce macrophage differentiation, M-CSF was added to the
culture medium at a final concentration of 50 ng/ml, and the
cells were further cultivated for 2 weeks with the medium ex-
changed every other day.
Isolation and culture of primary mouse hepatocytes
Primary mouse hepatocytes were isolated from livers of anes-
thetized wild-type and Cln7 ko mice by perfusion with oxygen-
ated perfusion buffer (pH 7.4) containing 0.14 M NaCl, 5 mM KCl,
0.8 mM MgCl2, 1.6 mM Na2HPO4, 0.4 mM KH2PO4, 25 mM NaHCO3,
2.5 mM EDTA, 16.5 mM glucose, 7.5 mM sodium lactate and 0.2
mM sodium pyruvate. Isolated hepatocytes were suspended in
culture medium (DMEM supplemented with Glutamax, 10% FBS
and penicillin/streptomycin) and centrifuged at 28g. Stromal
cells were removed by gradient centrifugation using 60%
Percoll. Hepatocytes were seeded in collagen-coated 12-well
plates at 2.5  105 cells/well, and the experiment was performed
the next day.
Treatment with lysosomal protease inhibitors
Immortalized MEFs were seeded in 60 mm dishes and cultured
to confluence. The cells were incubated in fresh medium sup-
plemented with lysosomal protease inhibitors at the indicated
concentrations for 20 h. Cells were washed twice with ice-cold
PBS, harvested and lysed in ice-cold PBS containing 0.5% (v/v)
Triton X-100 (TX-100), 1 mM EDTA and protease inhibitors. Total
protein extracts were analysed by immunoblotting.
Preparation of lysosome-enriched fractions
Following indicated treatment, MEFs were washed twice with
ice-cold PBS and harvested. The cells were resuspended in at
least 5-fold volume of ice-cold homogenization buffer (10 mM
phosphate buffer, pH 7.3, 250 mM sucrose, 1 mM EDTA, protease
inhibitors) and disrupted on ice by trituration (30 times) through
a 27-gauge needle attached to a syringe. The obtained homoge-
nate was further clarified from nuclei and unbroken cells at
1000g for 5 min at 4C, and the post-nuclear supernatant (PNS)
was collected in a new tube. The PNS was centrifuged at 20 000g
for 10 min at 4C and the pellet representing the lysosome-
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enriched fraction (LF) was resuspended in lysis buffer (50 mM
Tris–HCl, pH 7.4, 1% (v/v) TX-100, 150 mM NaCl, 1 mM EDTA, pro-
tease inhibitors) and incubated for 30 min on ice. Finally, LFs
were clarified by centrifugation at 16 000g for 15 min at 4C and
analysed by immunoblotting.
Membrane extraction assay
Wild-type and Cln7 ko MEFs grown in three 10 cm dishes were
incubated in the presence of E64 (10 mM) for 24 h. After removal
of the media, cells were washed three times with ice-cold PBS
and harvested by scraping. Light mitochondrial fractions (LMF),
containing lysosomes, prepared by differential centrifugation
were resuspended in ice-cold 10 mM Tris–HCl buffer (pH 7.5)
supplemented with protease inhibitors, and lysosomes were
disrupted by repeating cycles of freezing in dry ice/ethanol and
thawing at 37C for five times. Following sonication, LMFs were
centrifuged for 60 min at 100 000g at 4C to separate fractions
containing soluble lysosomal proteins (supernatant) and mem-
brane proteins (pellet). Membranes (100 mg protein) were further
extracted with 1% (v/v) TX-100 (total membranes) in 10 mM Tris–
HCl (pH 7.5) or 0.1 M Na2CO3 (pH 11) containing protease inhibi-
tors for 30 min on ice. After a final centrifugation at 100 000g for
30 min, supernatants and pellets were analysed by immuno-
blotting. For quantification of Cln5 in cells and media, MEFs
were incubated in Opti-MEM in the absence or presence of E64
(10 mM) for 24 h. Media were collected and concentrated
using Ultra centrifugal filters (Amicon). Total cell extracts and
aliquots of the conditioned media were analysed by western
blotting.
Immunoblotting
SDS-PAGE and immunoblotting were performed as described
previously (19). Immunoreactive band intensities were quanti-
fied by densitometry using Image Lab software (Bio-Rad).
Enzyme activity measurements
The enzymatic activities of lysosomal b-hexosaminidase
(Hexb), b-galactosidase (Glb), b-glucuronidase (Gusb) and
a-mannosidase (Man) in whole cell extracts of MEFs were
measured in a colorimetric or fluorometric assay using corre-
sponding 4-nitrophenyl- or 4-methylumbelliferyl- (MU) based
substrates (Supplementary Material, Table S3) (51, 52). All enzy-
matic assays were performed in a microplate format. A specific
enzyme activity of b-hexosaminidase was assayed at 37C in a
total volume of 30 ml. The assay mixture contained 100 mM so-
dium citrate (pH 4.6), 0.1% (v/v) TX-100, 0.2% (w/v) BSA and 4 mg
of a whole cell extract. The reaction was initiated with 5 mM
substrate and terminated after 45 min by adding 140 ml of
0.4 M glycine/NaOH (pH 10.4). The absorbance of the liberated
4-nitrophenol (e¼ 18 500 M1*cm1) was measured at 405 nm.
To measure activities of b-galactosidase, b-glucuronidase and
a-mannosidase, respectively 4, 8 and 16 mg of whole cell extracts
were added to the reaction mixture which consisted of a corre-
sponding substrate at given concentration, 100 mM sodium cit-
rate (pH 4.6), 0.1% (v/v) TX-100 and 150 mM NaCl, in a final
volume of 80 ml. After 5 h of incubation at 37C, the reaction was
terminated with 120 ml stop-buffer (0.4 M glycine/NaOH, pH 10.4)
and fluorescence of the released 4-methylumbelliferone (4-MU)
was measured using a Fluoroscan AscentTM microplate fluo-
rometer (Thermo Fischer Scientific) with excitation at 355 nm
and emission at 460 nm. For all fluorometric assays, a set of
standard concentrations of 4-MU was used to generate a cali-
bration curve and to calculate the amount of the released
product.
RNA isolation and quantitative RT-PCR
Total RNA was isolated from cultured MEFs using Peqgold Total
RNA kit according to the manufacturer’s instructions. The pu-
rity of the RNA samples was verified by visualization of 18S and
28S RNA bands after agarose gel electrophoresis. The High
Capacity cDNA Reverse Transcription kit was used to convert 1
mg of total RNA to cDNA following the manufacturer’s instruc-
tions. For the mRNA expression analysis, quantitative RT-PCR
was performed as described previously (28), on a Mx3000PVR
QPCR system (Stratagene) using pre-designed probes and pri-
mer sets (Supplementary Material, Table S4). The relative
mRNA expression levels were normalized to the expression lev-
els of Gapdh mRNA in the same sample using the comparative
2DDCT method.
Reactivation of mTORC1 activity during prolonged
starvation
Prolonged starvation of cultured MEFs was performed as de-
scribed previously (35). Confluent MEFs were washed three
times with PBS and incubated in either serum-containing
DMEM or amino acid- and serum-free Earle’s balanced salt solu-
tion (EBSS) for 2, 4, 6, 8 and 12 h. EBSS medium containing torin
1 (250 nM) was used for complete inhibition of mTORC1 reactiva-
tion in MEFs starved for 12 h.
Reactivation of mTORC1 activity after amino acid
starvation
MEFs were grown in complete growth medium to confluence.
After washing three times with PBS, cells were incubated for 60
min in amino acid- and serum-free EBSS. Cells were either har-
vested or incubated in amino acid-containing DMEM medium
lacking serum or EBSS containing 3% (w/v) BSA for 30, 60, 120
and 180 min. Cells incubated in the presence of the mTOR inhib-
itor torin 1 (250 nM) were used as positive control for complete
inhibition of mTORC1 activity. Cell pellets were lysed in 50 mM
Tris–HCl buffer (pH 7.5) containing 1% (v/v) TX-100, 150 mM NaCl
as well as phosphatase and protease inhibitors.
Statistical analysis of the data
The experiments were performed at least in triplicates, and the
data were plotted as mean6SD. The two-tailed Student’s t-test
was used to compare the obtained mean values. The difference
between the values was considered statistically significant if
P< 0.05 (*), P< 0.01 (**) and P< 0.001 (***). Statistical analyses
were performed using GraphPad Prism software.
Supplementary Material
Supplementary material is available at HMG online.
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